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The liver ﬂuke, Fasciola hepatica is an economically important pathogen of sheep and cattle and has been
described by the WHO as a re-emerging zoonosis. Control is heavily reliant on the use of drugs, particu-
larly triclabendazole and as a result resistance has now emerged. The population structure of F. hepatica is
not well known, yet it can impact on host–parasite interactions and parasite control with drugs, particu-
larly regarding the spread of triclabendazole resistance. We have identiﬁed 2448 potential microsatellites
from 83 Mb of F. hepatica genome sequence using msatﬁnder. Thirty-ﬁve loci were developed and opti-
mised for microsatellite PCR, resulting in a panel of 15 polymorphic loci, with a range of three to 15
alleles. This panel was validated on genomic DNA from 46 adult F. hepatica; 38 liver ﬂukes sourced from
a Northwest abattoir, UK and 8 liver ﬂukes from an established isolate (Shrewsbury; Ridgeway Research).
Evidence for null alleles was found at four loci (Fh_1, Fh_8, Fh_13 and Fh_14), which showed markedly
higher levels of homozygosity than the remaining 11 loci. Of the 38 liver ﬂukes isolated from cattle livers
(n = 10) at the abattoir, 37 genotypes were identiﬁed. Using a multiplex approach all 15 loci could be
ampliﬁed from several life cycle stages that typically yield low amounts of DNA, including metacercariae,
the infective life cycle stage present on pasture, highlighting the utility of this multiplex microsatellite
panel. This study reports the largest panel of microsatellite markers available to date for population stud-
ies of F. hepatica and the ﬁrst multiplex panel of microsatellite markers that can be used for several life
cycle stages.
 2015 The Authors. Published by Elsevier B.V. This is anopenaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
The liver ﬂuke, Fasciola hepatica, is a zoonotic trematode para-
site of grazing animals and humans. As the causative agent of
fasciolosis, it results in signiﬁcant global economic losses to the
livestock industry and is considered a re-emerging human disease,
currently included within the WHO top 17 listed neglected tropical
diseases (Mas-Coma et al., 2009; WHO, 2006, 2007, 2012). Over the
past decade the prevalence of F. hepatica infection has risen, in part
due to climate change, increased animal movement and changing
farming practices (van Dijk et al., 2010). Effective control andtreatment of fasciolosis in both humans and livestock is reliant
on anthelminitics, particularly the benzimidazole, triclabendazole
(TCBZ); the drug of choice, given its superior efﬁcacy against both
the immature and mature parasites. However, reliance on TCBZ has
led to widespread resistance (Overend and Bowen, 1995;
Fairweather, 2005; Brennan et al., 2007).
Fasciola has a complex life cycle that involves an intermediate
host, the mud snail Galba truncatula and multiple deﬁnitive hosts
(Supplementary Fig. 1). The ability of F. hepatica to infect a number
of different mammalian hosts is considered to be one of the factors
responsible for its extensive geographical reach (Mas-Coma, 2004;
Mas-Coma et al., 2005; Robinson and Dalton, 2009; Furst et al.,
2012). Eggs are passed onto the pasture in faeces from the deﬁni-
tive host. Following embryonation, miracidia hatch from the eggs
and infect the snail intermediate host, where a clonal expansion
of the parasite occurs, through sporocysts, rediae and cercariae life
cycle stages. Following release from the snail the infective stage,
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deﬁnitive host. Juvenile ﬂukes migrate to the bile ducts, where
they reach sexual maturity. In the mammalian host, the adult para-
sites undergo a complex reproductive strategy, with the potential
for self and cross fertilisation and parthenogenesis.
The asexual multiplication of F. hepatica within the snail host
and complex reproductive biology in the mammalian host facili-
tates high gene ﬂow and has the potential to promote high levels
of genetic variability within F. hepatica populations. Alternatively,
multiple permissive hosts may lead to host selection of F. hepatica
populations resulting in population sub-structuring and/or dif-
ferential genetic diversity in different hosts and geographical loca-
tions. How population structure may affect the spread of TCBZ
resistance throughout a population has yet to be investigated. To
fully understand the impact and spread of TCBZ resistance or any
genetic component that provides a survival advantage, the pop-
ulation structure of F. hepatica needs to be investigated, using a
large panel of polymorphic markers that are neutrally inherited.
This information is needed to determine how population dynamics
impact on host-parasite interactions and on parasite control
interventions.
Studies of the genetic structure of closely related trematodes,
including Clonorchis sinensis, Opisthorchis viverrini and
Schistosoma spp. have relied on a variety of molecular tools, in par-
ticular panels of microsatellite markers, to elucidate population
genetic structure (Gower et al., 2007, 2011; Agola et al., 2009;
Valentim et al., 2009; Laoprom et al., 2010; Xiao et al., 2011;
Glenn et al., 2013; Steinauer et al., 2010). The majority of studies
investigating the genetic structure of F. hepatica populations
involve the application of mitochondrial markers and/or small pan-
els of microsatellites (reviewed by Hodgkinson et al., 2013). To
date only ﬁve polymorphic microsatellites have been developed
and applied to Fasciola populations in Spain and Eqypt (Hurtrez-
Boussès et al., 2004; Dar et al., 2011, 2013; Vilas et al., 2012).
With the advancement of next generation technologies, trematode
genome datasets are now being mined for microsatellite markers
to develop panels of polymorphic markers; for example
Schistosoma japonicum (Xiao et al., 2011) and more recently
Fascioloides magna (Minarik et al., 2014). Here, we demonstrate
how 83 Mb of 454 FLX F. hepatica genome sequence data was used
to generate a resource of >2000 potential microsatellites, with suit-
able ﬂanking regions for primer design. Thirty-ﬁve loci were
selected for preliminary screening, resulting in the development
and characterisation of a panel of 15 polymorphic markers.
Genomic organisation of the panel of 15 microsatellite loci was
investigated by mining our recently generated 1.3 Gb F. hepatica
draft genome. Importantly, following an initial validation of these
markers their utility was demonstrated for multiple F. hepatica life
cycle stages that typically yield low amounts of DNA, particularly
eggs, miracidia and metacercariae stages; greatly facilitating pop-
ulation-level analyses across multiple geographical locations in
future.2. Methods
2.1. F. hepatica isolates
For development and validation of the microsatellite panel, 46
adult F. hepatica parasites were obtained from two sources: (1)
38 adult liver ﬂukes were recovered from livers of 10 naturally
infected cattle at an abattoir, in Northwest England, ranging
between one and seven adult liver ﬂukes from each liver; (2) eight
adult liver ﬂukes were tested from two cattle experimentally
infected with the Shrewsbury isolate (Ridgeway Research), with
one and seven adult liver ﬂukes from each animal, respectively.Each adult liver ﬂuke was genotyped individually. Eggs were har-
vested from adult F. hepatica parasites obtained from experimen-
tally infected animals, following incubation in 1–2 ml of
Dulbecco’s Modiﬁed Eagle’s Media (DMEM; Sigma Aldrich) for a
minimum of 2 h at 37 C. A subset of eggs was embryonated by
incubation at 26 C for 12 days. Following embryonation the eggs
were hatched to release miracidia using standard F. hepatica
protocols. Metacercariae were shed from experimentally
infected colonies of G. truncatula maintained at the University of
Liverpool.
2.2. DNA extraction and quantiﬁcation
Genomic DNA extraction was carried out using the DNeasy
Blood and Tissue Kit (Qiagen) for eggs, miracidia, metacercariae
and adults or Genomic tip 100G kit (Qiagen; adult parasites only),
according to the manufacturer’s instructions. Fifty eggs/miracidia/
metacerariae were used for each extraction and DNA was eluted
into 60 ll of AE buffer (DNeasy Blood and Tissue Kit; Qiagen).
Whole adult liver ﬂukes or a 20 mg section of adult liver ﬂuke near
the anterior sucker was used for extraction, followed by an ethanol
precipitation and re-suspension of the DNA in 60 ll TE (pH 8.0).
Chelex DNA extractions on single miracidia were carried out
according to Valentim et al. (2009), followed by whole genome
ampliﬁcation using the illustra GenomiPhi V2 DNA Ampliﬁcation
Kit in a reaction volume of 50 ll, according to the manufacturer’s
instructions (GE Healthcare Life Sciences). All DNA concentrations
were calculated using the Quant-iT™ PicoGreen dsDNA assay kit
(Life Technologies).
2.3. Genome sequencing and microsatellite identiﬁcation
F. hepatica genome sequence data was generated from genomic
DNA extracted from a single adult parasite (Sligo isolate; DNeasy
Blood and Tissue Kit, Qiagen), using 454 FLX sequencing technol-
ogy (Roche; Centre for Genomic Research, University of
Liverpool). The resulting 450 Mb of raw data was assembled into
190,089 contigs, representing 83 Mb of sequence data (ENA acces-
sion number PRJEB8349), which was mined for microsatellites
using msatﬁnder (www.genomics.ceh.ac.uk/msatﬁnder; default
thresholds; Thurston and Field, 2005). More than 2000 potential
microsatellites were identiﬁed comprising of di- to hexa-nu-
cleotide repeats with suitable ﬂanking regions for primer design
(Supplementary Table 1). The tri-and tetra- nucleotide motifs were
selected for further analysis, as they are known to be less prone to
enzyme slippage during PCR, which can make allele designation
difﬁcult (Edwards et al., 1991; Guichoux et al., 2011). Compound
microsatellites were excluded and the remaining microsatellites
were sorted according to the number of tandem repeats as per
Xiao et al. (2011). Thirty-ﬁve loci were selected for preliminary
PCR screening, which resulted in 15 loci being taken forward for
PCR ampliﬁcation using a modiﬁed semi-nested PCR protocol
based on Schuelke’s method (Schuelke, 2000). Genomic organ-
isation of the panel of 15 microsatellite loci was investigated by
mining the recently generated 1.3 Gb F. hepatica draft genome
sequenced from the Shrewsbury isolate (ENA accession numbers
LN627018-LN647175: assembly data and PRJEB6687: genomic
read data; Cwiklinski et al., in press), using BLAST (NCBI) and man-
ual curation.
2.4. Microsatellite PCR and capillary sequencing
Primary and secondary ampliﬁcation from adult genomic DNA
was carried out in a 10 ll reaction volume, containing 5 ll of 2
BioMix Red master mix (Bioline). The primary PCR contained 1 ll
of adult DNA template (10 ng) and 0.5 lM of both the forward
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MWG Operon). The cycling conditions were an initial 10 min at
94 C, followed by 25 cycles (see Table 1) at 94 C for 30 s, anneal-
ing temperature (see Table 1) for 45 s and 72 C for 45 s, with a
ﬁnal extension at 72 C for 10 min. The secondary PCR contained
1 ll of the primary PCR, 1 lM of the ﬂuorescent dye-M13 tagged
primer (50 6-FAM/NED/PET/VIC - TGTAAAACGACGGCCAGT 30; Life
Technologies) and 0.5 lM of the reverse primer (the same used
in the primary PCR). The cycling conditions were as above for 10
cycles with an annealing temperature of 53 C. To take advantage
of multiplex PCR protocols that offer distinct advantages when
low quantities of DNA are available, the 15 microsatellite markers
were subsequently validated using a multiplex PCR approach. Four
multiplex reactions were optimised using the Type-it
Microsatellite PCR kit (Qiagen) according to the manufacturer’s
instructions (30 cycles; Supplementary Table 2), using 1 ll of adult
genome DNA template. Microsatellite ampliﬁcation for the egg,
miracidia and metacercariae life cycle stages was carried out using
3 ll of the DNA template; with an increased number of PCR cycles
for both the semi-nested PCR (see Table 1) and multiplex PCR
approaches (40 cycles; Supplementary Table 2).
PCR products were analysed by agarose gel electrophoresis (2%
gel) using SYBR Safe DNA stain (Life Technologies). If a positive
result was obtained by gel electrophoresis, the PCR products were
diluted 50-fold and 1 ll of this dilution multiplexed in Hi-Di
Formamide (8.8 ll; Life Technologies) with GeneScan LIZ500 size
standards (0.2 ll; Life Technologies), prior to sequencing using a
3100 Genetic Analyzer capillary electrophoresis system (Life
Technologies).Table 1
Primer sequences and properties of F. hepatica (Fh) microsatellite alleles for the modiﬁed
Locus Primer sequence (50–30)
Fh_1* F: 50-TGTAAAACGACGGCCAGTCCCATGGTGTTGCACAGAT-30
R: 50-CTTCACCAAAAGCCGCTAAC-30
Fh_2* F: 50-TGTAAAACGACGGCCAGTTGAGAAACTGATTCACCGACTG-30
R: 50-GAGCTTGTGCTCTCGGAACTA-30
Fh_3* F: 50-TGTAAAACGACGGCCAGTCACGGCAACTGATGAATGAA-30
R: 50-TCCTCGTTTTTGGACCTCAG-30
Fh_4 F: 50-TGTAAAACGACGGCCAGTTCACGAAATTGGAGACGACA-30
R: 50-TGCATGCAAGAATTGTACCC-30
Fh_5 F: 50-TGTAAAACGACGGCCAGTCATCACCACTGTCTTCGATCA-30
R: 50-CGAAGCATTGATAAGATTTCCA-30
Fh_6 F: 50-TGTAAAACGACGGCCAGTACGTCCGTCCGTTAAGTGAG-30
R: 50-TTTGAGGTCGACATCCTTCA-30
Fh_7* F: 50-TGTAAAACGACGGCCAGTTGCACTCTAGCATGGTTTGG-30
R: 50-AAGTCTTCAGTGCCCCTTCC-30
Fh_8 F: 50-TGTAAAACGACGGCCAGTCTCCTGAGGATGATCGGAAA-30
R: 50-CTACCGGATCGTTTTGACCA-30
Fh-9 F: 50-TGTAAAACGACGGCCAGTAACCCGTATCACCACCAAAC-30
R: 50-CTCCCAATCCTGCCATACAT-30
Fh_10 F: 50-TGTAAAACGACGGCCAGTTTTAGTCGCGGAGCTACCAT-30
R: 50-CCACTTTCGTCATGCACATT-30
Fh_11 F: 50-TGTAAAACGACGGCCAGTTAAACCGTTGCTTCACGTTG-30
R: 50-CAAAGTGTTTGGCGAGCTG-30
Fh_12* F: 50-TGTAAAACGACGGCCAGTCCACGAGAAGTGGAATTCGT-30
R: 50-GTAGGTCCACTCCCTGTCCA-30
Fh_13* F: 50-TGTAAAACGACGGCCAGTGAAACTGTCCCGAAAACGAG-30
R: 50-GCGTGCAACATAGGTGAAAA-30
Fh_14* F: 50-TGTAAAACGACGGCCAGTACAGGGCTTTGAAGCATGAC-30
R: 50-GGGATAGAGCCGTACTGGAA-30
Fh_15* F: 50-TGTAAAACGACGGCCAGTAATGCGGAAAAGAGCGATTA-30
R: 50-GAAATTGGGAGCAACTGCAT-30
Primer sequence: sequence underlined represents the M13 sequence tag. Ta: annealing
* Loci that can be consistently ampliﬁed from egg, miracida and metacercariae DNA.
^ DNA extracted from egg, miracida and metacercariae life cycle stages.2.5. Data analysis
Sequence size was determined with an ABI PRISM 3100 DNA
analyzer and Peak Scanner v1.0 software. Analysis was carried
out using GENEPOP version 4.0.10 (Raymond and Rousset, 1995;
Rousset, 2008), Genetix (Belkhir et al., 2004) and Micro-Checker
(van Oosterhout et al., 2004). Each of the markers produced clear,
unambiguous traces for individual parasites as expected for single
locus markers in a diploid organism.
3. Results
3.1. Validation of F. hepatica microsatellite panel
The 83 Mb F. hepatica genome sequence data, comprised of
190,089 contigs was mined for microsatellite markers resulting
in 5222 potential microsatellite loci; 2448 of which were identiﬁed
with suitable primer ﬂanking regions. To investigate the utility of
these microsatellites as a tool for population level studies a subset
of 15 loci were validated using 46 individual adult parasites from
cattle; 38 liver ﬂukes sourced from naturally infected cattle and
eight liver ﬂukes sourced from experimentally infected cattle. All
15 loci studied were found to be polymorphic, with allele numbers
ranging from three-15 (Table 2; Supplementary Table 3). For the 38
liver ﬂukes isolated from naturally infected cattle, 37 multi-locus
genotypes (MLG) were reported. Hardy–Weinberg equilibrium
(HWE) and the heterozygote deﬁciency for each locus were exam-
ined using the exact test, using GENEPOP version 4.0.10 (Table 2).
Three loci (Fh_1, Fh_8 and Fh_14) were found to signiﬁcantlySchuelke’s method.
Dye Ta (C) No. PCR cycles
Adult DNA template Other DNA templates^
VIC 55 25 45
VIC 57 25 45
PET 58 25 45
PET 59 25 /
6-FAM 57 25 /
6-FAM 55 25 /
6-FAM 57 25 45
NED 57 25 /
PET 58 25 /
NED 57 25 /
PET 57 25 /
VIC 60 25 50
PET 55 25 50
NED 57 25 50
NED 55 25 55
temperature for PCR.
Table 2
Statistical analysis of the 15 F. hepatica microsatellite loci.
Locus Repeat motif Locus size (bp) No. of alleles Allele size range (bp) HE HO FIS HW
Fh_1 TTTG 201 4 200–224 0.564 0.196 0.656 0.000
Fh_2 TTGA 213 16 200–356 0.826 0.733 0.087 0.134
Fh_3 AAAC 196 5 195–219 0.655 0.651 0.030 0.088
Fh_4 TAA 186 13 178–214 0.859 0.739 0.140 0.002
Fh_5 ACT 159 15 166–338 0.850 0.800 0.057 0.071
Fh_6 TAT 180 15 193–265 0.861 0.913 0.061 0.486
Fh_7 TAT 177 13 178–259 0.759 0.698 0.081 0.593
Fh_8 ATA 167 11 180–213 0.821 0.533 0.353 0.000
Fh-9 GTT 203 3 210–225 0.332 0.400 0.117 0.032
Fh_10 TAA 217 12 215–251 0.790 0.891 0.130 0.210
Fh_11 ATA 211 14 209–254 0.877 0.711 0.191 0.000*
Fh_12 ATC 215 8 219–258 0.705 0.652 0.075 0.921
Fh_13 CAT 192 4 202–226 0.648 0.444 0.327 0.002
Fh_14 AAT 201 10 202–238 0.808 0.318 0.634 0.000
Fh_15 TATG 206 7 213–277 0.598 0.630 0.071 0.002
Locus size: represents the size of the locus found in the F. hepatica genomic sequence data using msatﬁnder. HE: expected heterozygosity and HO: observed heterozygosity;
calculated using GENETIX. FIS: inbreeding coefﬁcient, according to Weir and Cockerham (1984) and HW: Fisher’s exact test for Hardy–Weinberg equilibrium, P < 0.00005 after
Bonferroni’s adjustment; calculated using GENEPOP. In bold are the three loci that signiﬁcantly deviate from HWE following Bonferroni’s adjustment (P < 0.00005).
* Not signiﬁcant after Bonferroni’s adjustment (0.0002).
Table 3
Location of microsatellite loci within the draft F. hepatica genome*.
Loci Location in draft genome (ENA scaffold number) Size of scaffold/bp
Fh_1 LN629046 119,809
Fh_2 LN627942 830,113
Fh_3 LN627685 203,809
Fh_4 LN627551 495,632
Fh_5 LN627876 548,152
Fh_6 LN629193 178,014
Fh_7 LN635535 32,950
Fh_8 LN629482 110,497
Fh_9 LN628826 266,251
Fh_10 LN628015 227,781
Fh_11 LN629076 121,942
Fh_12 LN628360 220,783
Fh_13 LN630045 119,190
Fh_14 LN628821 190,238
Fh_15 LN627509 452,066
* Cwiklinski et al., in press. Data are freely available from the European
Nucleotide Archive under accessions LN627018-LN647175 (assembly data),
PRJEB6687 (genomic read data).
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(P < 0.00005; Rice, 1989). All were signiﬁcant for heterozygote
deﬁciency (P < 0.00005). In addition four loci (Fh_1, Fh_8, Fh_13
and Fh_14) were found to have potential null alleles (as observed
by plots of FIS vs number of alleles and FIS vs heterozygosity
(Supplementary Fig. 2). These loci together within an additional
two loci (Fh_4 and Fh_11) were also identiﬁed as potential null
alleles (calculated using Micro-Checker). All 15 loci were consis-
tently ampliﬁed, produced unambiguous traces and were sufﬁ-
ciently polymorphic to provide a robust panel of microsatellites
for accurately genotyping F. hepatica parasites.
3.2. Genotyping multiple F. hepatica life cycle stages
To fully exploit their potential the microsatellite markers were
validated as a means of genotyping several life cycle stages of F.
hepatica; namely eggs, miracidia and metacercariae. A subset of
eight loci consistently and accurately genotyped pools of 50 meta-
cercariae (Fh_1, Fh_2, Fh_3, Fh_4, Fh_7, Fh_12, Fh_13, Fh_14 and
Fh_15; Table 1) and three loci in particular (Fh_1, Fh_2, Fh_3) could
reliably genotype fewer than 50 metacercariae. Following this ini-
tial validation the panel was tested on duplicate samples of eggs,
miracidia and metacercariae (50 of each) from four different iso-
lates, whose genetic proﬁle was known. Microsatellite analysis of
these samples showed that the resulting genotype was consistent
with each isolate proﬁle. Multiple alleles for each locus were repre-
sented within each population of eggs indicating the markers were
capable of deﬁning populations of parasites. To improve
microsatellite ampliﬁcation from these life cycle stages that typi-
cally yield low levels of DNA, a multiplex protocol was used, which
resulted in consistent ampliﬁcation for the whole panel of 15
loci. Finally DNA extraction and subsequent ampliﬁcation of
microsatellites was optimised for a single miracidium, using
Chelex DNA extraction with or without subsequent whole genome
ampliﬁcation. DNA was extracted from 10 individual replicate mir-
acidia of known genotype and the expected proﬁle was consis-
tently ampliﬁed either directly or following whole genome
ampliﬁcation, suggesting that individual miracidia can be success-
fully genotyped using this approach.
3.3. Genomic location of F. hepatica microsatellites
The microsatellites were originally identiﬁed in our preliminary
83 Mb F. hepatica genome dataset and their presence and locationwas subsequently conﬁrmed by mining our recently generated
1.3 Gb F. hepatica draft genome (Cwiklinski et al., in press). All loci
were detected and found to reside on discrete scaffolds that ranged
in size from 33 to 830 Mbp indicating that these loci are dispersed
throughout the genome (Table 3). Linkage disequilibrium (LD)
analysis carried out on the subset of nine loci where potential null
alleles were not observed according to the more conservative
Micro-Checker analysis (Fh_2, Fh_3, Fh_5, Fh_6, Fh_7, Fh_9,
Fh_10, Fh_12, and Fh_15), showed signiﬁcant results for several
microsatellite pairs (Table 4).4. Discussion
This study reports the characterisation of a panel of 15 novel
polymorphic microsatellites, constituting the largest panel of
microsatellite markers available for F. hepatica. These loci were
identiﬁed from within a database of >2000 microsatellite loci,
which was compiled from 83 Mb F. hepatica genome sequence
data. Following the sequencing of the complete F. hepatica genome
(Cwiklinski et al., in press), we now know that 83 Mb of sequence
data represents only 6.5% of the 1.3 Gb draft F. hepatica genome.
The identiﬁcation of this large number of microsatellite loci from
such a small proportion of genomic sequence shows the potential
Table 4
Genotypic linkage disequilibrium for the nine F. hepatica microsatellite loci where
null alleles were not identiﬁed.
Fh pairs P-value*
Fh_2 & Fh_6 0.000000
Fh_2 & Fh_7 0.000000
Fh_2 & Fh_10 0.000054
Fh_2 & Fh_12 0.000000
Fh_3 & Fh_6 0.000000
Fh_3 & Fh_10 0.000005
Fh_3 & Fh_12 0.001212
Fh_5 & Fh_6 0.000118
Fh_5 & Fh_7 0.000000
Fh_5 & Fh_10 0.000724
Fh_5 & Fh_12 0.001220
Fh_6 & Fh_10 0.000000
Fh_6 & Fh_12 0.000000
Fh_10 & Fh_12 0.000095
* P < 0.05 following Bonferroni’s adjustment = P < 0.0014238.
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genetic studies in the future.
The liver ﬂuke samples chosen for the validation of these loci
were sourced from 12 different animals, 10 of which were natu-
rally infected with F. hepatica. All of the parasites obtained from
each of the 10 naturally infected animals were used for this study,
a total of 38 liver ﬂukes, to allow an initial observation of the
genetic proﬁle of liver ﬂukes found in an animal. Eight liver ﬂukes
from two experimentally infected animals were also tested, which
was consistent with the number of adult liver ﬂukes observed in a
naturally infected cow.
Statistical analysis showed that these loci are polymorphic with
a wide range of alleles, highlighting the suitability of these loci to
further understand the population genetics of F. hepatica. Null
alleles were potentially identiﬁed for at least four loci (Fh_1,
Fh_8, Fh_13 and Fh_14), which exhibited notably higher levels of
homozygosity (measured by FIS) than the remaining 11 loci.
Whereas parthenogenesis in Fasciola is known and could lead to
higher inbreeding and FIS across the genome, the higher levels of
FIS observed during this study at the subset of four loci suggests
locus-speciﬁc effects, for which the presence of null alleles is a
parsimonious explanation. A further two loci were potentially
identiﬁed using the Micro-Checker algorithm (Fh_4 and Fh_11).
Given the complex nature of the Fasciola life cycle the loci that
have been identiﬁed as null alleles would need to be veriﬁed in a
larger study and any future statistical analysis interpreted with
caution, especially if the method of reproduction (asexual vs sex-
ual) is not known for the speciﬁc isolate. It should be noted that
analysis of the UK isolates used for this particular study have been
shown to reproduce sexually and are diploid (Beesley et al.,
unpublished).
Several loci pairs were found to have signiﬁcant LD values. As
these values could be inﬂuenced by the population structure
within this panel, speciﬁcally by those loci that were not in
HWE, those loci showing potential null alleles were omitted from
this analysis. The fact that the samples used for this analysis came
from several animals and therefore from several potential pop-
ulations of F. hepatica, could also explain the LD values. LD was
not calculated per animal due to the small number of liver ﬂukes
obtained. Analysis of a larger population would give a more accu-
rate representation of the LD. Analysis of the location of the 15 loci
within the draft F. hepatica genome has shown that they are pre-
sent on discrete scaffolds. Although the loci are thought not to
be closely located, those loci with signiﬁcant LD values could be
present in areas of the genome that are co-inherited. Also as the
genome is still in a draft format and with a wide range of scaffoldsizes (33–830 Mbp), these loci may be more closely located than
presently thought. Further annotation of the scaffolds where the
loci are located is required to investigate the genes closely located
to the microsatellite loci on the scaffolds and how this may affect
their heritability. With the availability of single molecule sequenc-
ing, the assembly of the F. hepatica genome can also be improved,
providing further information regarding the location of these loci.
An important aspect of this study involved the optimisation of
the microsatellite panel for three different life cycle stages; eggs,
miracidia and metacercariae. Typically these stages yield low
amounts of DNA and are a signiﬁcant challenge to investigate,
yet are important as they represent the more readily accessible
stages of the parasite on pasture, avoiding the need to passage cer-
cariae through a mammalian host (Supplementary Fig. 1). Existing
studies have concentrated on the adult stage of the F. hepatica life
cycle but the ability of our microsatellite panel to robustly geno-
type multiple life cycle stages, potentially at the single miracidium
level, offers signiﬁcant promise for population genetic, molecular
epidemiology and studies of the transmission dynamics of
F. hepatica in future. Eight loci were shown to be robust, being con-
sistently ampliﬁed from samples of 50 eggs/miracidia/metacercar-
iae. In fact prior to multiplexing the markers, three of the loci could
be ampliﬁed from fewer than 50 metacercariae (Fh_1, Fh_2 and
Fh_3). It should be noted that although using pools of parasite
material (speciﬁcally eggs and miracidia from populations of F.
hepatica) allows the extraction of sufﬁcient DNA for microsatellite
analysis, this method can only be used to give an overall represen-
tation of the potential alleles present within those populations.
Capillary sequencing of microsatellite PCRs can often result in stut-
ter peaks, n-1 peaks or large allelic drop-out, which could result in
a greater number of alleles for pooled samples from a given pop-
ulation, though the multiplex protocol was optimised to minimise
these effects. Microsatellite analysis of individual miracidia or
metacercariae resulting from single snail: miracidia infections,
although more time consuming, would give a more accurate repre-
sentation of the number of alleles present within a population.
With this in mind we adopted the protocol of Valentim et al.
(2009), that involves extracting DNA using Chelex followed by
whole genome ampliﬁcation, to successfully genotype DNA from
individual F. hepatica miracidia using our panel of 15 markers.
These results show the potential power of this method for F. hepa-
tica populations, although further analysis is required using greater
numbers of miracidia from different populations to accurately
determine the error rate using this method for natural populations.
Levels of genetic variability within populations of the Fasciola
genus from different hosts and geographical locations are currently
not well understood, in particular, the impact of population
dynamics on the development of anthelmintic resistance. To date
the majority of studies investigating the genetic structure of
Fasciola populations have focussed on available mitochondrial
markers. Sequencing of the complete F. hepatica mitochondrial
genome of two geographically distinct isolates (Australia and Salt
Lake City) showed that these genomes demonstrate levels of
intra-speciﬁc variation <1% of the 14 kb mitochondrial genome
(Le et al., 2001). Mitochondrial markers have been applied to inves-
tigate TCBZ resistance in cattle in the Netherlands (Walker et al.,
2011) and Teofanova and colleagues have shown that partial
mitochondrial DNA sequences are also useful for population genet-
ics analysis (Teofanova et al., 2011). However, it should be noted
that mitochondrial markers have been shown to have potential
limitations, including the fact that direct and indirect selection
can inﬂuence mitochondria resulting in mitochondrial DNA not
always being a strict neutral marker (Ballard and Whitlock, 2004;
Galtier et al., 2009). Coupled with the fact that F. hepatica has a
complex life cycle, including an asexual component all Fasciola
spp. population genetics data should be interpreted with caution.
K. Cwiklinski et al. / Infection, Genetics and Evolution 32 (2015) 298–304 303Prior to this study only a small panel of microsatellites was
available (Hurtrez-Boussès et al., 2004). Several of these loci were
tested as part of this study, with inconsistent results (data not
shown). This original panel was developed using F. hepatica para-
sites from the Bolivian Altiplano. These results could indicate that
there is potential polymorphism at the microsatellite primer sites
between geographically distinct Fasciola spp. isolates, and so the
panel outlined within this study should be tested on samples from
different geographical areas from large populations to give an
accurate representation of the utility of this panel and the
population genetic structure of F. hepatica isolates.
Studies have shown that microsatellites developed for one spe-
cies can often be used in related species (Jarne and Lagoda, 1996;
Gemmell et al., 1997; Dar et al., 2011). In particular one study
showed that the F. hepatica loci identiﬁed by Hurtrez-Boussès
et al. (2004) could be used for the related species Fasciola gigantica
(Dar et al., 2011), indicating the potential of the microsatellite
panel described within this study to be used for other Fasciola spe-
cies. Nevertheless, with the expansion of next generation sequenc-
ing technologies, large genomic datasets are more readily available
for mining, particularly for genetic markers, providing potential for
a F. gigantica-speciﬁc microsatellite panel.
The availability of this polymorphic panel will allow extensive
study of the population structure of F. hepatica. In particular these
markers will provide insight into geographically distinct isolates,
advancing our understanding of a parasite which has a complex life
cycle and the ability to infect a number of mammalian hosts. The
availability of this panel of microsatellite loci also allows the
population structure of F. hepatica, found in areas of differential
exposure to TCBZ, to be explored, which will be invaluable for
the continued study of TCBZ resistance.
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